Video Programs

Title: Faculty: Credit Hours: Evaluating Clinical Use of Long-Acting GLP-1 Therapy in Type 2 Diabetes Treatment Regimens Patrick J. Boyle, MD This program has been approved for up to 1.50 credits. Long-Acting GLP-1 Receptor Agonist Therapy: Improving Efficacy, Adherence, and Weight in T2DM Ralph A. DeFronzo, MD, Chair; John B. Buse, MD, PhD; David D`Alessio, MD This program has been approved for up to 1.50 credits. Shared Decision Making for Clinical Success in the Obese Person with Type 2 Diabetes Patrick J. Boyle, MD, Janice L. Koshinsky, RN, MS, CDE, Frank Lavernia, MD Clinical Shared Decision Making with the Obese Person with Type 2 Diabetes and A BMI >35 Patrick J. Boyle, MD, Janice L. Koshinsky, RN, MS, CDE, Frank Lavernia, MD Personalized Health Risk Management and Therapeutic Decision-Making in Type 2 Diabetes Patrick J. Boyle, MD and Frank Lavernia, MD Successfully Implementing Personalized Decision Making in Type 2 Diabetes Janice L. Koshinsky, RN, MS, CDE and Frank Lavernia, MD Practical Opinions: Personalizing Patient Treatment Goals and Care Management in a Recently Diagnosed Type 2 Diabetes Patient Patrick J. Boyle, MD, Janice L. Koshinsky, RN, MS, CDE, Frank Lavernia, MD Practical Opinions-Personalizing Patient Treatment Goals and Care Management in an Older Patient with Established Type 2 Diabetes Patrick J. Boyle, MD, Janice L. Koshinsky, RN, MS, CDE, Frank Lavernia, MD Effective Use of InsulinThrough the Progression of Type 2 Diabetes - Q & A Silvio Inzucchi, MD and Geralyn Spollett, MSN, ANP, CDE This program has been approved for up to 1.50 credits. Effective Use of Insulin Through the Progression of Type 2 Diabetes Silvio Inzucchi, MD and Geralyn Spollett, MSN, ANP, CDE This program has been approved for up to 1.50 credits.